Key personnel

In addition to the key personnel listed above, the Lung Pathway Group is made up of a multi-disciplinary team of clinicians from primary, secondary and tertiary LCA providers covering the cancer pathway.

Introduction to the pathway group

The lung pathway group aims to improve access, experience and outcomes for lung cancer patients in south and west London. The membership of the group brings together specialist expertise from primary, secondary and tertiary care as well as patients and users of the service to enable development of high quality patient centred care.

The lung pathway group supports the aims and objectives of the LCA - to provide world class cancer services across south and west London. It aims to improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education with particular emphasis on earlier diagnosis.

Overall project objectives

  • Review evidence and current performance of pathways within the LCA with regard to outcomes, model of care recommendations and best practice.
  • Develop improvement plans and make recommendations for improvement to the Clinical Board.
  • Undertake a baseline audit of the performance of each organisation against delivery of the relevant model of care recommendations. The audit will include review against the model of care co-dependency framework.
  • Agree and establish current best practice and develop an exemplar best practice pathway.
  • Undertake a baseline assessment against the exemplar pathway, confirming the extent to which practice in each organisation is in line with this best practice.
  • Ensure the appropriate level of engagement with patients, primary care and other key stakeholders, such as public health, ensuring bi-annual stakeholder events.
  • Be compliant with peer review requirements.
  • Merge existing guidelines for each cancer network within the LCA to produce a single document used across the LCA. If these do not already exist the pathway group will produce a new set of guidelines for the LCA on its specific tumour site or pathway.

Lung-specific objectives

  • Ensure thoracic surgeons provide input to all lung multi-disciplinary team management recommendations in the LCA.
  • Ensure lung cancer surgery providers in London perform at least 60 resections a year, including diagnostic and therapeutic lung cancer surgery.
  • Explore the consolidation of lung cancer surgery to two or three providers in the LCA, each serving a population in excess of 2 million, and advise on feasibility of implementation.
  • Ensure that agreed pathways are established and monitor the outcomes for patients.
  • Review progress against agreed service metrics and advise corrective action where these are not achieved.
  • Develop best practice recommendations for the treatment of lung cancer in older patients.
  • Develop best practice recommendations for the non-surgical treatment of patients with early stage lung cancer.
  • Review access to stereotactic radiotherapy, the NRIG recommended treatment of choice for inoperable peripheral non small cell lung cancer, across the LCA and develop treatment pathways in response to the review.


  • Development of a comprehensive and seamless exemplar lung pathway across the LCA based upon national and international standards, research and evidence.
  • Respond to the recommendations in the model of care.
  • Improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education.
  • To improve care and ensure equitable access to specialists, GPs, hospitals and healthcare professionals, thus improving the outcomes of the population of London.
  • Development of a set of outcome and patient experience metrics to measure performance of lung cancer providers across the LCA and patient pathway.
Close ×